Hospira
Hospira, Inc. is a global provider of injectable drugs and infusion technologies, headquartered in Lake Forest, Illinois. The company develops, manufactures, and distributes a diverse range of products that include over 200 injectable generic drugs, proprietary specialty injectables, and biosimilars for various therapeutic applications. Key offerings include drugs like Precedex for sedation, Retacrit for anemia treatment, and Inflectra for autoimmune diseases. Additionally, Hospira supplies medication management products such as infusion pumps, safety software systems, and related services to healthcare providers including hospitals and clinics. Their commitment to enhancing patient and caregiver safety while reducing healthcare costs is reflected in their innovative solutions and collaborative partnerships. Founded in 2003, Hospira employs around 16,000 individuals and operates internationally across the Americas, EMEA, and APAC regions. Since 2015, it has functioned as a subsidiary of Pfizer Inc.
Top Stages
2 past transactions
BresaGen
Acquisition in 2006
BresaGen is a developer of proteins and peptides, especially biogenerics. In October 2006, BresaGen was sold to Hospira Inc of the US, and Paragon made a 2.35x return on investment, and 135% IRR. Hospira acquired the company to further develop BresaGen’s intellectual property, and to distribute its products in the US.
Physiometrix
Acquisition in 2005
Physiometrix is a medical device firm that manufactures non-invasive medical products for use in anesthesia. The company was founded in 1990 and is headquartered in Billerica, Massachusetts, United States.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.